Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

• Status: Suspended
• Trial end date: 2023-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to examine the genetic material called microRNA of three types of specimens from women with breast cancer. The study also seeks to examine the effectiveness of using a new agent called oxytocin to increase the amount of nipple fluid that can be collected during surgery.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sheldon Feldman
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• Clinical diagnosis of Ductal carcinoma in situ (DCIS) or invasive breast cancer

• Candidate for breast conserving surgery or mastectomy

Exclusion Criteria:

• Pregnant women

• Prior Breast Cancer diagnosis

• Adverse reaction to Oxytocyn in the past